Moxifloxacin Ophthalmic Solution Solution/ Drops
NDC Package 67296-2222-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Moxifloxacin Ophthalmic Solution (moxifloxacin) solution/ dropses is moxifloxacin ophthalmic solution  is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species*Micrococcus luteus*Staphylococcus aureusStaphylococcus epidermidisStaphylococcus haemolyticusStaphylococcus hominisStaphylococcus warneri*Streptococcus pneumoniaeStreptococcus viridansgroup Acinetobacter lwoffii*Haemophilus influenzaHaemophilus parainfluenzae*Chlamydia trachomatis*Efficacy for this organism was studied in fewer than 10 infections. This formulation utilizes a solution/ drops delivery system. Marketed by Redpharm Drug, this product is identified by NDC 67296-2222 and is authorized under FDA application ANDA217988.

Identification & Billing

NDC Package Code
67296-2222-3
Package Description
1 BOTTLE in 1 CARTON / 3 mL in 1 BOTTLE
Product Code
67296-2222
11-Digit Billing Format
67296222203

Clinical Specifications

Proprietary Name
Moxifloxacin Ophthalmic Solution
Non-Proprietary Name
Moxifloxacin
Substance Name
Moxifloxacin Hydrochloride
Dosage Form
Solution/ Drops - A solution which is usually administered in a drop-wise fashion.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
MOXIFLOXACIN HYDROCHLORIDE 5 mg/mL
Pharmacologic Class
Usage Information
Moxifloxacin ophthalmic solution  is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species*Micrococcus luteus*Staphylococcus aureusStaphylococcus epidermidisStaphylococcus haemolyticusStaphylococcus hominisStaphylococcus warneri*Streptococcus pneumoniaeStreptococcus viridansgroup Acinetobacter lwoffii*Haemophilus influenzaHaemophilus parainfluenzae*Chlamydia trachomatis*Efficacy for this organism was studied in fewer than 10 infections.

Regulatory & Marketing

Labeler Name
Redpharm Drug
Product Type
Human Prescription Drug
FDA Application #
ANDA217988
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-27-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67296-2222-3 identifies a specific commercial package of 1 bottle in 1 carton / 3 ml in 1 bottle of Moxifloxacin Ophthalmic Solution, a human prescription drug labeled by Redpharm Drug. This solution/ drops is formulated for ophthalmic use and contains moxifloxacin hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Redpharm Drug on January 27, 2025. The current certification is valid through December 31, 2027.

How is this Redpharm Drug product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67296222203. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
67296-2222-3
11-Digit CMS (5-4-2)
67296-2222-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.